Great Information on Rare Diseases and Orphan Drugs

DAN LIMBACH | February 8, 2017

article image
If you work in the rare disease space, you will be very interested in this blog post. Publicis Touchpount Solutions recently published an outstanding white paper on rare diseases and orphan drugs. It’s packed with valuable statistics, research findings, images, and charts. Compared to most white papers, it’s a fairly deep dive, with 25 pages in total, including links to additional reference materials.

Spotlight

W. L. Gore & Associates

Gore is a materials science company whose Associates are driven by curiosity and the opportunity to improve lives through our products and innovations. Working closely and collaboratively with our customers, we devise best-fit solutions that work the first time and every time delivering a high standard of reliability expected by our customers and the people they serve. With products ranging from medical devices that treat aneurysms to high-performance GORE-TEX® Fabrics, and with over 2,000 patents granted in our 60-year history, we’re committed to innovations that improve lives.

OTHER ARTICLES

How pharma can continue engaging HCPs in a world gripped by COVID-19

Article | April 10, 2020

Medscape is the leading source of clinical news, health information, and point-of-care tools for healthcare professionals. Medscape offers specialists, primary care physicians, and other health professionals the most robust and integrated medical information and educational tools. Medscape Education (medscape.org) is the leading destination for continuous professional development, consisting of more than 30 specialty-focused destinations offering thousands of free CME and CE courses and other educational programmes for physicians, nurses, and other healthcare professionals. Both Medscape and Medscape Education are part of WebMD Health Corp., an Internet Brands company. Face-to-face interactions between pharma and physicians have essentially ceased overnight during the COVID-19 pandemic, but that doesn’t mean HCPs have stopped looking for new medical information.

Read More

WANT LESS “LIABILITY” AND MORE “RELIABILITY” FROM YOUR CLINICAL MOBILITY SOLUTION?

Article | April 10, 2020

I recently discussed the different ways that consumer-grade smartphones can compromise patients’ health, safety and overall care. However, some clinicians and healthcare administrators have indicated in recent months that they need help selecting the right enterprise-grade mobility solutions for their unique operating models and workflows. There are many different hardware and software options, and a single rugged device can come in multiple configurations. So, how do you know if you’re picking the right communication tools for your clinicians? The key is to first set performance expectations for the total mobility solution rather than the device alone.

Read More

5 Pharma Trends and Their Impact on Packaging

Article | April 10, 2020

The pharmaceutical industry is changing at an unprecedented pace. New biological treatments for cancer, and a dramatic rise of widespread diseases such as diabetes, call for new processing and packaging solutions to fulfill the different needs all over the world. Keep your eye on these five main packaging trends for 2020 for the global pharmaceutical market.

Read More

Merck’s Patient-Centric Clinical Trial Recruiting

Article | April 10, 2020

Everyone in pharma knows that product success depends on the results of clinical trials — but we don’t usually hear from the people who are involved in running them. Recently, four Clinical Research Managers (CRM) from Merck (known as MSD outside the United States and Canada) discussed how Merck is overcoming the barriers to clinical trial recruitment by adopting a patient-centric process — a model that affects their trials top to bottom, from design through implementation. Each of the panel members manages clinical trials, serving as the main point of interaction with the Clinical Research Associates (CRAs) on research requirements, goals, and resources, including recruiting and retention.

Read More

Spotlight

W. L. Gore & Associates

Gore is a materials science company whose Associates are driven by curiosity and the opportunity to improve lives through our products and innovations. Working closely and collaboratively with our customers, we devise best-fit solutions that work the first time and every time delivering a high standard of reliability expected by our customers and the people they serve. With products ranging from medical devices that treat aneurysms to high-performance GORE-TEX® Fabrics, and with over 2,000 patents granted in our 60-year history, we’re committed to innovations that improve lives.

Events